Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting Hartley will also present new data on Orion’s CCR2 antagonist, OB-004, demonstrating the ability of this

Oliver Hartley. Below is your Classified GPCR News at a glance for March 20th to 26th, 2023.

Oliver Hartley, Dr. Pierre Eftekhari, Dr. Lauren Slosky, Dr. Christel Menet, Dr. Ben Myers and Dr.

Oliver Hartley About Dr. Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

Oliver Smithies at UNC-CH, where she was the first to discover the essential role of adrenomedullin peptide